CH623062A5 - - Google Patents

Download PDF

Info

Publication number
CH623062A5
CH623062A5 CH1444875A CH1444875A CH623062A5 CH 623062 A5 CH623062 A5 CH 623062A5 CH 1444875 A CH1444875 A CH 1444875A CH 1444875 A CH1444875 A CH 1444875A CH 623062 A5 CH623062 A5 CH 623062A5
Authority
CH
Switzerland
Prior art keywords
group
methylene
hydrogen atom
hydroxy
pregnen
Prior art date
Application number
CH1444875A
Other languages
German (de)
English (en)
Inventor
Rudolf Prof Dr Wiechert
Klaus Dr Kieslich
Henning Dr Koch
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of CH623062A5 publication Critical patent/CH623062A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C07J53/008—3 membered carbocyclic rings in position 15/16

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH1444875A 1974-11-11 1975-11-07 CH623062A5 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2453823A DE2453823C2 (de) 1974-11-11 1974-11-11 11β,17α-Dihydroxy-15α,16α-methylen-1,4-pregnadien-3,20-dion

Publications (1)

Publication Number Publication Date
CH623062A5 true CH623062A5 (fi) 1981-05-15

Family

ID=5930733

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1444875A CH623062A5 (fi) 1974-11-11 1975-11-07

Country Status (9)

Country Link
US (1) US4012510A (fi)
JP (2) JPS645880B2 (fi)
BE (1) BE835427A (fi)
CH (1) CH623062A5 (fi)
DE (1) DE2453823C2 (fi)
DK (1) DK142057C (fi)
FR (1) FR2290214A1 (fi)
GB (1) GB1530615A (fi)
NL (1) NL7513156A (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040265948A1 (en) * 2003-06-27 2004-12-30 White Michael Jon Microbial method for hydrolysis and oxidation of androst-5-ene and pregn-5-ene steroid esters
DE102008026793A1 (de) * 2008-06-02 2009-12-03 Bayer Schering Pharma Aktiengesellschaft C-Ring-substituierte Pregn-4-en-21,17-carbolactone, sowie diese enthaltende pharmazeutische Präparate
US8729108B2 (en) * 2008-06-17 2014-05-20 Christopher J Dannaker Waterborne topical compositions for the delivery of active ingredients such as azelaic acid
CA3090724A1 (en) * 2018-02-11 2019-08-15 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Steroid derivative regulators, method for preparing the same, and uses thereof
WO2022115381A1 (en) * 2020-11-25 2022-06-02 Sage Therapeutics, Onc. Compositions and methods for treating cns disorders cross reference to related application

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH573447A5 (en) * 1971-06-11 1976-03-15 Hoffmann La Roche 21-hydroxy-11-beta-hydroxy (or 11-oxo) -15-beta, 16-beta - - methylene pregn-4-en-3,20-diones prepn - by 21-hydroxylation or oxi
US3438975A (en) * 1966-07-01 1969-04-15 Syntex Corp 15alpha,16alpha-methylene pregnanes and 19-nor-pregnanes
CH529734A (de) * 1969-12-17 1972-10-31 Hoffmann La Roche Verfahren zur Herstellung neuer Steroide der Pregnanreihe
US3700702A (en) * 1970-12-02 1972-10-24 Hoffmann La Roche New 15{62 ,16{62 -methylene steroids
DE2246462C3 (de) * 1972-09-21 1981-07-23 Schering Ag Berlin Und Bergkamen, 1000 Berlin 15 α , 16 α -Methylen-4-pregnene, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
DE2337333A1 (de) * 1973-07-23 1975-02-20 American Cyanamid Co Steroidacetonide und ihre verwendung

Also Published As

Publication number Publication date
BE835427A (fr) 1976-05-10
DE2453823A1 (de) 1976-05-20
FR2290214A1 (fr) 1976-06-04
DK142057C (da) 1981-01-19
JPS62187486A (ja) 1987-08-15
DE2453823C2 (de) 1984-08-09
JPS645880B2 (fi) 1989-02-01
DK142057B (da) 1980-08-18
NL7513156A (nl) 1976-05-13
JPS5191392A (fi) 1976-08-10
FR2290214B1 (fi) 1978-08-18
US4012510A (en) 1977-03-15
GB1530615A (en) 1978-11-01
JPH0148760B2 (fi) 1989-10-20
DK503775A (da) 1976-05-12

Similar Documents

Publication Publication Date Title
EP0072547A1 (de) Neue 6-alpha-Methylprednisolon-Derivate ihre Herstellung und Verwendung
DE1154102B (de) Verfahren zur Herstellung therapeutisch wirksamer Steroidverbindungen
DE2349022A1 (de) Neue d-homo-steroide
CH618704A5 (fi)
CH623062A5 (fi)
EP0054786B1 (de) Neue 6-alpha-Methylhydrocortison-Derivate, ihre Herstellung und Verwendung
EP0039311B1 (de) Halogenierte Steroide
EP0003341B1 (de) 11,17-substituierte Pregnane, ihre Herstellung und Verwendung zur Herstellung von pharmazeutischen Präparaten
DE2839033A1 (de) 3-oxo-4-pregnen-20 alpha -carbonsaeure- derivate, ihre herstellung und verwendung
DE2349023A1 (de) Neue d-homo-steroide
CH633562A5 (de) Verfahren zur herstellung neuer kortikoide.
EP0276393B1 (de) Verfahren zur Herstellung von 6Alpha, 9Alpha-Difluor-11Beta, 17Alpha-dihydroxy-16Alpha-methyl-4-pregnen-3,20-dion und dessen Derivate
EP0013959B1 (de) Neue D-Homosteroide, Verfahren zu deren Herstellung und diese D-Homosteroide enthaltende Arzneimittel
DE1904544C3 (de) Verfahren zur mikrobiologischen Umwandlung von 3 ß-Hydroxy-5,6- epoxysteroiden in 6-Hydroxy-3-KetoA<·4 -Steroide
DE2059310C3 (de) diese enthaltende Arzneimittel sowie Verfahren zu ihrer Herstellung
EP0033120B1 (de) 1-Hydroxysteroide, Verfahren zu ihrer Herstellung und pharmazeutische Präparate, die diese Verbindungen enthalten
EP0032103B1 (de) Neue Kortikoid-17-thioacetale, ihre Herstellung und Verwendung
DE1904543C3 (de) Verfahren zur mikrobiologischen Umwandlung von 3 ß-Hydroxy-5,6- epoxysteroiden in 6-Hydroxy-3-Keto- A4 -Steroide
DE2753839A1 (de) Neue kortikoide
DE2656575A1 (de) Neue kortikoide
DE1150385B (de) Verfahren zur Herstellung von 6ª‡-Halogen-bzw. 6ª‡, 9ª‡-Dihalogen-pregnenen
CH629828A5 (en) Process for the preparation of D-homosteroids
DE1158063B (de) Verfahren zur Herstellung von therapeutisch wirksamen Steroidverbindungen
DE2803661A1 (de) Neue in 17-position substituierte 11beta-hydroxysteroide der pregnanreihe, ihre herstellung und verwendung
DE2144585A1 (de) Ester von 9alpha-fluor-16-methylenprednisolon

Legal Events

Date Code Title Description
PL Patent ceased